The largest database of trusted experimental protocols

7 protocols using ncl dysb

1

Dystrophin Quantification in Muscle

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isopentane-frozen diaphragm strip, heart, and quadriceps muscle specimens obtained at the conclusion of the study were sectioned at 8-μm thickness and immunostained per standard techniques for dystrophin/microdystrophin (Leica, NCL-DYSB) as previously described. (Hamm et al., 2021 (link)). Evaluation of percent dystrophin- or microdystrophin-positive fibers was performed by a neuropathologist using a standard fluorescent microscope and estimated to the nearest 5%.
+ Open protocol
+ Expand
2

Immunoblotting Protocols for Dystrophin and DNA Repair Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
For dystrophin immunoblots, denaturated protein samples from cell lysates were run in 4–10% gradient polyacrylamide gel for 70 min/170 V/400 mA, blotted at 100 V/300 mA for 2 h and labeled with antibody against N terminal (NCL-DYSB, Leica) and C terminal (ab15277, abcam) of dystrophin protein. As a loading control, tubulin or laminB were used. Human heart atrial tissue was obtained as procedural surplus material, available during bicaval orthotopic heart transplantation from donor organs. For western blot analysis, the sample was homogenized and dissolved in RIPA buffer (10 mM Tris-Cl (pH 8.0), 1 mM EDTA, 0.5 mM EGTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS, 140 mM NaCl, 1 mM phenylmethanesulfonyl fluoride) and the supernatant was used.
For DNA repair protein expression, 10% polyacrylamide gel was run for 60 min/170 V/400 mA and blotted for 1 h. Proteins were labeled with antibodies against ligase1, ligase 3, ligase 4, NBS1, Rad51 and APE1 in dilution as stated in Supplementary material (Table S10).
+ Open protocol
+ Expand
3

Immunohistochemical Analysis of Muscle Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical analysis involved the use of immunoperoxidase techniques on frozen sections. MANDYS110 clone 3H10, provided by the Wolfson Centre for Inherited Neuromuscular Disease, NCL-DYSB and NCL-DYS2 (Novocastra Laboratories, Newcastle on Tyne, UK) mouse monoclonal antibodies were used for dystrophin protein detection (1∶50 for each ones). Other primary antibodies used were IVD31A9 (1∶50, Developmental Studies Hybridoma Bank, Iowa City, IA), NCL-g-Sarc (1∶10, Novocastra Laboratories) and NCL-DRP2 (1∶60, Novocastra Laboratories) for alpha-sarcoglycan, gamma-sarcoglycan, and utrophin detection respectively, NCL-MHCd (1∶20, Novocastra Laboratories) for developmental myosin heavy chain isoform, anti-complement 5b-9 (1∶250, Calbiochem, Strasbourg, France) and anti-CD3 (1∶100, Dako, Glostrup, Denmark) for lymphocytes. Briefly, transverse cryosections were incubated in PBS with 5% normal goat serum (Dako) for 1 hour at room temperature. They were then incubated with primary antibody in 5% rat serum overnight at 4°C and with biotinylated secondary antibodies (E433, 1∶300, Dako) in PBS with 5% rat serum for 1 hour. Bound antibodies were detected either with streptavidin (P397; Dako) and DAB Liquid Substrate (Dako) for immunoperoxidase. Fiber type was determined using histochemical myosin-ATPase reaction after preincubation at pH 4.2, 4.35, and 10.4 as previously described [22] .
+ Open protocol
+ Expand
4

Dystrophin and Associated Proteins Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse monoclonal antibodies against N-terminal (34C5: Product code NCL-DYSB) and C-terminal (MANDRA1: Product number SAB4200763) dystrophin were purchased from Novocastra Laboratories (Newcastle upon Tyne, UK) and Merck/Sigma-Aldrich (Tokyo, Japan), respectively. Rabbit polyclonal antibodies against utrophin (UT-2), β-dystroglycan (β-DGs), and α-sarcoglycan (α-SG3) have been previously described39 (link). Peroxidase-conjugated anti-mouse and anti-rabbit antibodies were purchased from Beckman Coulter (Brea, CA, USA) and Merck/Sigma-Aldrich. Alexa Fluor 488-conjugated anti-mouse and rabbit antibodies were purchased from Thermo Fisher Scientific KK (Tokyo, Japan).
+ Open protocol
+ Expand
5

Cardiac Troponin T and Dystrophin Immunostaining

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunostaining was performed using anticardiac troponin T (Abcam, Cambridge, Massechusetts) and antidystrophin (NCL-DYSB, against dystrophin protein epitope amino acids 321-494 encoded by exons 10-12; Leica Biosystems, Buffalo Grove, Illinois) along with labeled secondary antibodies (Life Technologies). Cells were counterstained with 4’,6-diamidino-2-phenylindole or Hoechst nuclear stains. Images were captured with a confocal microscope (Nikon A1-R; Nikon Instruments, Melville, New York).
+ Open protocol
+ Expand
6

CRISPR Editing of iPSCs for Duchenne Muscular Dystrophy

Check if the same lab product or an alternative is used in the 5 most similar protocols
CRISPR target sites within exon 1 were identified using ZiFit Targeter version 4.2 (F: CACCGATACACTTTTCAAAAT GCTT and R: AAACAAGCATTTTGAAAAGT GTATC) and were cloned into pX330-U6-Chimeric-BB-CBh-hspCas9 (Addgene plasmid no 42230) as described previously44 (link). An AAVS1 Safe Harbor TALE-Nuclease Kit including pAAVS1 Dual Promoter Donor Vector (GE602A-1) and the TALEN Vectors, pZTAAVS1 L1 TALEN Vector (GE601A-1) and pZT-AAVS1 R1 TALEN Vector (GE601A-1) was purchased from System Biosciences (Palo Alto, CA). HB53-iPSCs were transfected with or without all necessary components using 4D-Nucleofector (Lonza, Basel, Switzerland). Cells that underwent transfection by 4D Nucleofector but did not contain any targeting components were sub-cloned to generate the isogenic WT2-iPCS line. Following transfection with the targeting components, iPSCs were plated on mouse embryonic feeder cells for 9 days, and selected for puromycin resistance. Clones were picked, replated on Matrigel and sent out for DMD exon 1 sequencing (Retrogen, San Diego, CA). DysC-iPSCs were found to contain a 6 bp deletion in exon 1 and DysC-iCMs were identified as dystrophin deficient as shown by immunofluorescence (NCL-DysB, Leica Biosystems, Wetzlar, Germany) (Supplemental Fig. 2).
+ Open protocol
+ Expand
7

Dystrophin Protein Analysis by Western Blotting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proteins were analyzed by Western blotting. Each protein extract was mixed with one volume of Laemmli sample buffer (Bio-Rad Laboratories, Inc., Hercules, CA, USA) and boiled for 5 min. Precision Plus ProteinTM All Blue Standards (Bio-Rad Laboratories) were used as protein size markers. Equal amounts of protein (3 µg) were separated on 4-20% SDS-PAGE gels (Criterion TGX precast Gels, Bio-Rad) and electrotransferred to PVDF membrane using an iBlot2 transfer system (Thermo Fisher Scientific). The membranes were blocked with StartingBlock T20 blocking reagent (Thermo Fisher Scientific) and incubated overnight at 4 ℃ with 1:100 dilutions of antibodies to the N-terminal of dystrophin (NCL-DYSB, Leica Biosystems, Wetzler, Germany), the C-terminal of dystrophin (ab15277, abcam, Cambridge, UK) and a 1:1000 dilution of antibody to vinculin (ab129002, abcam) as a loading control. After washing, the membranes were incubated with a 1:20,000 dilution of secondary HRP-coupled antibody to rabbit for ab15277 and ab129002 (GE Healthcare Life Sciences) and to mouse for NCL-DYSB (GE Healthcare Life Sciences). After washing, the membranes were processed for enhanced chemiluminescence detection using Luminata Forte Western HRP substrate (EMD Millipore, Billerica, MA, USA). Immunoreactive proteins were visualized by Amersham Imager 680RGB (GE Healthcare Life Sciences).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!